Top News

Novavax's Debt Overview

NVAX) moved higher by 165.32%. Before we understand the importance of debt, let’s look at how much debt Novavax has.

Novavax’s Debt

Based on Novavax’s balance sheet as of August 10, 2020, long-term debt is at $321.32 million and current debt is at $5.08 million, amounting to $326.40 million in total debt. Adjusted for $424.39 million in cash-equivalents, the company’s net debt is at $-97.99 million.

To understand the degree of financial leverage a company has, shareholders look at the debt ratio. Considering Novavax’s $932.23 million in total assets, the debt-ratio is at 0.35. As a rule of thumb, a debt-ratio more than 1 indicates that a considerable portion of debt is funded by assets. A higher debt-ratio can also imply that the company might be putting itself at risk for default, if interest rates were to increase. However, debt-ratios vary widely across different industries. A debt ratio of 40% might be higher for one industry, whereas average for another.

Why Shareholders Look At Debt?

Besides equity, debt is an important factor in the capital structure of a company, and contributes to its growth. Due to its lower financing cost compared to equity, it becomes an attractive option for executives trying to raise capital.

However, interest-payment obligations can have an adverse impact on the cash-flow of the company. Having financial leverage also allows companies to use additional capital for business operations, allowing equity owners to retain excess profit, generated by the debt capital.

View Article Origin Here

Related Articles

Back to top button